Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Myriad Genetics (MYGN) over the last 16 years, with Dec 2024 value amounting to $1.7 million.

  • Myriad Genetics' Interest & Investment Income rose 25.00% to $500,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 38.10%. This contributed to the annual value of $1.7 million for FY2024, which is 32.00% down from last year.
  • According to the latest figures from FY2024, Myriad Genetics' Interest & Investment Income is $1.7 million, which was down 32.00% from $2.5 million recorded in FY2023.
  • Over the past 5 years, Myriad Genetics' Interest & Investment Income peaked at $3.0 million during FY2020, and registered a low of $700,000 during FY2021.
  • For the 3-year period, Myriad Genetics' Interest & Investment Income averaged around $2.3 million, with its median value being $2.5 million (2023).
  • As far as peak fluctuations go, Myriad Genetics' Interest & Investment Income plummeted by 65.00% in 2021, and later spiked by 271.43% in 2022.
  • Over the past 5 years, Myriad Genetics' Interest & Investment Income (Yearly) stood at $3.0 million in 2020, then reached $2.0 million in 2020, then slumped by 65.00% to $700,000 in 2021, then soared by 271.43% to $2.6 million in 2022, then fell by 3.85% to $2.5 million in 2023, then crashed by 32.00% to $1.7 million in 2024.